Alice Pomponio is Vice President of Innovation and Impact Investing at American Cancer Society and Managing Director of BrightEdge, ACS’s mission-driven VC and innovation arm which invests in early-stage companies poised to end cancer as we know it for everyone. She has held patient-centered design roles at Sanofi, Genzyme, AstraZeneca, US OMB, UK FCO and trained at MIT (BS) and Harvard (MPP).